Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Communications Medicine|September 2, 2022
ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancerRodney P Rocconi, Laura Stanbery, Min Tang, et al.
Advances in Medical Sciences|May 25, 2019
Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myelomaAleksander Salomon-Perzyński, Adam Walter-Croneck, Lidia Usnarska-Zubkiewicz, et al.
Cancer Gene Therapy|March 23, 2021
Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancerRodney P Rocconi, Erin E Stevens, Justin N Bottsford-Miller, et al.
Genome Medicine|October 1, 2015
A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseasesNeil A Miller, Emily G Farrow, Margaret Gibson, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Successful classification of clinical pediatric leukemia genetic subtypes via structural variant detection using HiFi long-read sequencingLisa A Lansdon, Byunggil Yoo, Ayse Keskus, et al.
The New England Journal of Medicine|June 3, 2015
Elotuzumab Therapy for Relapsed or Refractory Multiple MyelomaSagar Lonial, Meletios Dimopoulos, Antonio Palumbo, et al.
Blood Cancer Journal|September 5, 2020
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 studyMeletios A Dimopoulos, Sagar Lonial, Darrell White, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
DeepSomatic: Accurate somatic small variant discovery for multiple sequencing technologiesJimin Park, Daniel E Cook, Pi-Chuan Chang, et al.
Pageof 6